LBF20207PG65: Difference between revisions
(New page: {{Lipid/Header}} {{Hierarchy|{{PAGENAME}}}} {{Metabolite |LipidBank=XPR1734 |LipidMaps=LMFA03010052 |SysName=(9alpha,15R) -Dihydroxy-11-oxo-16,16-dimethyl-prost- (5-cis,13-trans) -dien-1...) |
No edit summary |
||
| Line 6: | Line 6: | ||
|LipidBank=XPR1734 | |LipidBank=XPR1734 | ||
|LipidMaps=LMFA03010052 | |LipidMaps=LMFA03010052 | ||
|SysName=(9alpha,15R) -Dihydroxy-11-oxo-16,16-dimethyl-prost- (5- | |SysName=(9alpha,15R) -Dihydroxy-11-oxo-16,16-dimethyl-prost- (cis-5,trans-13) -dien-1-oic acid | ||
|Common Name=&&16,16-dimethyl Prostaglandin D_2&&(9alpha,15R) -Dihydroxy-11-oxo-16,16-dimethyl-prost- (5Z,13E) -dien-1-oic acid&& | |Common Name=&&16,16-dimethyl Prostaglandin D_2&&(9alpha,15R) -Dihydroxy-11-oxo-16,16-dimethyl-prost- (5Z,13E) -dien-1-oic acid&& | ||
|Source= | |Source= | ||
Latest revision as of 08:45, 21 October 2010
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | XPR1734 |
| LipidMaps | LMFA03010052 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20207PG65 |
| 16,16-dimethyl Prostaglandin D2 | |
|---|---|
| |
| Structural Information | |
| (9α,15R) -Dihydroxy-11-oxo-16,16-dimethyl-prost- (cis-5,trans-13) -dien-1-oic acid | |
| |
| Formula | C22H36O5 |
| Exact Mass | 380.256274262 |
| Average Mass | 380.51824000000005 |
| SMILES | CCCCC(C)(C)C(O)C=CC(C(=O)1)C(CC=CCCCC(O)=O)C(O)C1 |
| Physicochemical Information | |
| 16,16-dimethyl Prostaglandin D2 enhances ADP-induce human platelet aggregation and increase systemic blood pressure in rat. Bundy_GL et al. | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
